Project includes $97 million in government funding and additional investments from PomeGran through financing partnerships with the Canada Infrastructure Bank and Stonebridge Financial Corporation. TORONTO, June 24, 2024 /PRNewswire/ – PomeGran Inc. (PomeGran), Canada’s fastest growing…

AUCKLAND, New Zealand, June 24, 2024 /PRNewswire/ — Douglas Pharmaceuticals, New Zealand’s largest pharmaceutical company, is pleased to announce that results from their recent trial, “Randomised Placebo-Controlled Phase 2 Study of Extended-Release Ketamine Tablets (R-107) for…